Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers

Human Psychopharmacology

Volumn 24, Issue 7, 2009, Pages 559-564

  Sofuoglu, Mehmet ^a   Mitchell, Ellen ^a   Mooney, Marc ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gender differences; Gonadal hormones; IV nicotine; Nicotine; Progesterone; Sex differences

Indexed keywords

NICOTINE; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; HEART RATE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SEX DIFFERENCE; SINGLE DRUG DOSE; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; WITHDRAWAL SYNDROME;

ADULT; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ESTRADIOL; FEMALE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; NICOTINE; NICOTINIC AGONISTS; PROGESTERONE; PROGESTINS; QUESTIONNAIRES; SEX FACTORS; SMOKING; SMOKING CESSATION;

EID: 72849112692     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1055     Document Type: Article

References (38)

1. Allen SS, Bade T, Center B, et al. 2008. Menstrual phase effects on smoking relapse. Addiction 103(5): 809-821.
2. Baulieu EE. 1998. Neurosteroids: a novel function of the brain [In Process Citation]. Psychoneuroendocrinology 23(8): 963-987.
3. Becerra L, Breiter HC, Wise R, et al. 2001. Reward circuitry activation by noxious thermal stimuli. Neuron 32(5): 927-946. (Pubitemid 34024851)
4. Bell SL, Taylor RC, Singleton EG, et al. 1999. Smoking after nicotine deprivation enhances cognitive performance and decreases tobacco craving in drug abusers [In Process Citation]. Nicotine Tob Res 1(1): 45-52.
5. Buchhalter AR, Acosta MC, Evans SE, et al. 2005. Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction 100(4): 550-559.
6. Bullock AE, Clark AL, Grady SR, et al. 1997. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem 68(6): 2412-2423.
7. Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT. 2006. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a rewiew. Nicotine Tob Res 8(5): 627-638.
8. Chabbert Buffet N, Djakoure C, Maitre SC, et al. 1998. Regulation of the human menstrual cycle. Front Neuroendocrinol 19(3): 151-186.
9. Chait LD, Corwin RL, Johanson CE, et al. 1988. A cumulative dosing procedure for administering marijuana smoke to humans. Pharmacol Biochem Behav 29(3): 553-557.
10. Cox LS, Tiffany ST, Christen AG, et al. 2001. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3(1): 7-16.
11. Cyr M, Ghribi O, Di Paolo T, et al. 2000. Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain. J Neuroendocrinol 12(5): 445-452. (Pubitemid 30223992)
12. Dar DE, Zinder O. 1997. Short term effect of steroids on catecholamine secretion from bovine adrenal medulla chromaffin cells [In Process Citation]. Neuropharmacology 36(11-12): 1783-1788. (Pubitemid 28085940)
13. de Lignieres B. 1999. Oral micronized progesterone. Clin Ther 21(1): 41-60 discussion 1-2.
14. Dreher JC, Schmidt PJ, Kohn P, et al. 2007. Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci USA 104(7): 2465-2470. (Pubitemid 46391419)
15. Evans SM, Foltin RW. 2006. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 31(3): 659-674.
16. Heatherton TF, Kozlowski LT, Frecker RC, et al. 1991. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addictions 86: 1119-1127.
17. Henningfield JE, Miyasato K, Jasinski DR, et al. 1985. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234(1): 1-12. (Pubitemid 15034883)
18. Hughes JR, Hatsukami D. 1986. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43(3): 289-294.
19. Hughes JR, Hatsukami DK. 1997. Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight. J Subst Abuse 9: 151-159.
20. Jackson LR, Robinson TE, Becker JB, et al. 2006. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 31(1): 129-138. (Pubitemid 43250948)
21. Jensen J, McIntosh AR, Crawley AP, et al. 2003. Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron 40(6): 1251-1257. (Pubitemid 38032799)
22. Jones HE, Garrett BE, Griffiths RR, et al. 1999. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther 288(1): 188-197.
23. Justice AJ, de Wit H. 2000. Acute effects of estradiol pretreatment on the response to d- amphetamine in women. Neuroendocrinology 71(1): 51-59. (Pubitemid 30045335)
24. McNair D, Lorr M, Dropperman L, et al. 1988. Profile of Mood States: Bipolar Form. Educational and Industrial Testing Service: San Diego.
25. Morgan MJ, Davies GM, Willner P, et al. 1999. The questionnaire of smoking urges is sensitive to abstinence and exposure to smoking-related cues. Behav Pharmacol 10(6-7): 619-626. (Pubitemid 30026056)
26. Paradiso K, Sabey K, Evers AS, et al. 2000. Steroid inhibition of rat neuronal nicotinic alpha4beta2 receptors expressed in HEK 293 cells. Mol Pharmacol 58(2): 341-351. (Pubitemid 30497478)
27. Simon JA. 1995. Micronized progesterone: vaginal and oral uses. Clin Obstet Gynecol 38(4): 902-914.
28. Simon JA, Robinson DE, Andrews MC, et al. 1993. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil Steril 60(1): 26-33.
29. Smith SS. 1991. Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells. Neuroscience 42(2): 309-320.
30. Sofuoglu M, Babb DA, Hatsukami DK, et al. 2001. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol Biochem Behav 69(1-2): 299-304. (Pubitemid 32566275)
31. Sofuoglu M, Babb DA, Hatsukami DK, et al. 2002. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol Biochem Behav 72(1-2): 431-435. (Pubitemid 34251355)
32. Sofuoglu M, Babb D, Hatsukami DK, et al. 2003. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers. Nicotine Tob Res 5(6): 947-953. (Pubitemid 38029091)
33. Sofuoglu M, Mitchell E, Kosten TR, et al. 2004. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav 78(4): 699-705. (Pubitemid 39037728)
34. Sofuoglu M, Poling J, Mouratidis M, et al. 2006. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berl) 184(3-4): 645-651. (Pubitemid 43255881)
35. Tiffany ST, Drobes DJ. 1991. The development and initial validation of a questionnaire on smoking urges. Br J Addict 86(11): 1467-1476.
36. Walsh SL, Preston KL, Sullivan JT, et al. 1994. Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Ps ychopharmacol 14(6): 396-407. (Pubitemid 24378141)
37. Walsh SL, Sullivan JT, Preston KL, et al. 1996. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther 279(2): 524-538.
38. Zumoff B, Miller L, Levin J, et al. 1990. Follicular-phase serum progesterone levels of nonsmoking women do not differ from the levels of nonsmoking men. Steroids 55(12): 557-559.